This Article Full Text Full Text (PDF) All Versions of this Article: 41/2/361    most recent 01.HYP.0000052831.85600.79v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Castellano, M. Articles by Agabiti-Rosei, E. Search for Related Content PubMed PubMed Citation Articles by Castellano, M. Articles by Agabiti-Rosei, E. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Related Collections Clinical genetics Other hypertension Epidemiology Genetics of cardiovascular disease

(Hypertension. 2003;41:361.)
© 2003 American Heart Association, Inc.

Scientific Contributions

ß₂-Adrenergic Receptor Gene Polymorphism, Age, and Cardiovascular Phenotypes

Maurizio Castellano; Federica Rossi; Mara Giacchè; Cristiano Perani; Francesca Rivadossi; Maria Lorenza Muiesan; Massimo Salvetti; Marina Beschi; Damiano Rizzoni; Enrico Agabiti-Rosei

From the Department of Medical and Surgical Sciences, University of Brescia, Italy.

Correspondence to Prof Maurizio Castellano, Scienze Mediche e Chirurgiche, Università di Brescia, c/o 2 Medicina, Spedali Civili, 25100 Brescia, Italy. E-mail castell{at}master.cci.unibs.it

Previous studies suggest that variants of the ß₂-adrenergic receptor (ADRB2) may differently affect functional responses to adrenergic stimulation, thereby possibly modulating cardiovascular and metabolic phenotypes. We examined the hypothesis that G/R16 and Q/E27 polymorphism of ADRB2, or their haplotypes, may modulate blood pressure, cardiovascular structure, and function or metabolic cardiovascular risk factors in the general population. We examined a random sample of the general population (n=571; age, 35 to 64 years). Neither clinic nor 24-hour ambulatory blood pressure was significantly associated with ADRB2 genotypes in the overall population. Cardiac structure and function were also not influenced by ADRB2 polymorphism. After adjustment for potential confounders, association of the R16 allele with higher systolic blood pressure was observed in the subgroup of younger people (below age of 50 years). Haplotype analysis showed that higher blood pressure values were more specifically associated with the presence of R16-Q27. Younger people carrying the R16-Q27 haplotype also showed a trend toward lower heart rate, higher BMI, lower glycemia, and higher trygliceridemia, which is consistent with the hypothesis of a genetic predisposition to reduced cardiovascular and metabolic response to ADRB2 stimulation. This study does not provide evidence of a major role of ADRB2 gene variability in blood pressure modulation. However, association of ADRB2 polymorphism with cardiovascular and metabolic effects can be observed in younger subjects, before the development of age-related decline of ADRB2-mediated activity. Our study emphasizes the necessity of taking into account (patho)-physiological changes related to aging (in this case, decreased efficiency of ADRB2 signaling) when analyzing phenotypic effects of genetic variants.

Key Words: receptors, adrenergic beta • polymorphism • genetics • blood pressure • age • metabolism

This article has been cited by other articles:

				M. Hassan, K. M. York, H. Li, Q. Li, Y. Gong, T. Y. Langaee, R. B. Fillingim, J. A. Johnson, and D. S. Sheps Association of {beta}1-Adrenergic Receptor Genetic Polymorphism With Mental Stress-Induced Myocardial Ischemia in Patients With Coronary Artery Disease Arch Intern Med, April 14, 2008; 168(7): 763 - 770. [Abstract] [Full Text] [PDF]

				C. Kaymak, N. A. Kocabas, E. Durmaz, and D. Oztuna {beta}2 Adrenoceptor (ADRB2) Pharmacogenetics and Cardiovascular Phenotypes during Laryngoscopy and Tracheal Intubation International Journal of Toxicology, November 1, 2006; 25(6): 443 - 449. [Abstract] [Full Text] [PDF]

				N Charkoudian, M. J Joyner, C. P Johnson, J. H Eisenach, N. M Dietz, and B. G Wallin Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation J. Physiol., October 1, 2005; 568(1): 315 - 321. [Abstract] [Full Text] [PDF]

				X. Bao, P. J. Mills, B. K. Rana, J. E. Dimsdale, N. J. Schork, D. W. Smith, F. Rao, M. Milic, D. T. O'Connor, and M. G. Ziegler Interactive Effects of Common {beta}2-Adrenoceptor Haplotypes and Age on Susceptibility to Hypertension and Receptor Function Hypertension, August 1, 2005; 46(2): 301 - 307. [Abstract] [Full Text] [PDF]

				K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck {beta}2- and {beta}3-Adrenergic Receptor Polymorphisms Are Related to the Onset of Weight Gain and Blood Pressure Elevation Over 5 Years Circulation, June 28, 2005; 111(25): 3429 - 3434. [Abstract] [Full Text] [PDF]

				L. Covolo, U. Gelatti, M. Metra, S. Nodari, A. Piccichè, N. Pezzali, C. Zani, A. Alberti, F. Donato, G. Nardi, et al. Role of {beta}1- and {beta}2-adrenoceptor polymorphisms in heart failure: a case-control study Eur. Heart J., September 1, 2004; 25(17): 1534 - 1541. [Abstract] [Full Text] [PDF]

				T. Lucas, D. Losert, M. Allen, J. Halaschek-Wiener, B. Pratscher, C. Friedrich, M. Wolschek, G. Fuchsjager-Mayrl, L. Schmetterer, H. Pehamberger, et al. Combination Allele-Specific Real-Time PCR for Differentiation of {beta}2-Adrenergic Receptor Coding Single-Nucleotide Polymorphisms Clin. Chem., April 1, 2004; 50(4): 769 - 772. [Full Text] [PDF]

				S. L. Kirstein and P. A. Insel Autonomic Nervous System Pharmacogenomics: A Progress Report Pharmacol. Rev., March 1, 2004; 56(1): 31 - 52. [Abstract] [Full Text] [PDF]